Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

GlaxoSmithKline to look for early-stage assets: CEO

GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker’s chief executive officer said.

Read More »

FDA chief to meet e-cigarette makers amid crackdown

The U.S. Food and Drug Administration plans to meet with top-level executives of e-cigarette makers, the agency’s chief said, hinting that some companies seem to be backing away from commitments related to youth’s access to e-cigarettes.

Read More »

Ex-Insys CEO to plead guilty to opioid kickback scheme

The former chief executive of Insys Therapeutics Inc. agreed to plead guilty to participating in a scheme to bribe doctors.

Read More »

Rapidly taking patients off opioids might not be a good idea, experts say

Forcing patients off opioid painkillers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities.

Read More »

FDA panel backs prescribing overdose reversal drug with opioids

An advisory panel to the U.S. Food and Drug Administration narrowly recommended prescribing the opioid overdose reversal drug naloxone along with addictive painkillers.

Read More »

FDA declines to approve Mallinckrodt’s abuse-deterrent opioid painkiller

The U.S. Food and Drug Administration declined to approve an abuse-deterrent version of Mallinckrodt Plc’s opioid painkiller Roxicodone, saying some parts of the company’s application need further evaluation.

Read More »

Opioid maker Insys paid kickbacks to physician assistant, jury hears

A former Insys Therapeutics Inc. sales representative now married to the drugmaker’s ex-CEO said she arranged to have a physician assistant in New Hampshire receive kickbacks to prescribe patients its addictive fentanyl spray.

Read More »

Scientists to test tailor-made vaccine tech to fight epidemics

A global coalition set up to fight disease epidemics is investing up to $8.4 million to develop a synthetic vaccine system that could be tailor-made to fight multiple pathogens such as flu, Ebola, Marburg and rabies.

Read More »

New cases of HIV rise in Eastern Europe, decline in the West

More than 130,000 people were newly diagnosed with HIV last year in Eastern Europe – the highest rate ever for the region – while the number of new cases in Western Europe declined, global public health experts said.

Read More »

U.S. to restrict e-cigarette flavors

The FDA will issue a sales ban on fruit and candy flavored electronic cigarettes in convenience stores and gas stations in a move to counter a surge in teenage use of e-cigarettes.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!

Subscribe

Ad Right Bottom